High Financial Hardship among Patients with Advanced Ovarian Cancer-Reference-Cited by-同舟云学术

High Financial Hardship among Patients with Advanced Ovarian Cancer

Published:2024-04-02 Issue:2 Volume:20 Page:120-132
ISSN:1552-4256
Container-title:Journal of Social Work in End-of-Life & Palliative Care
language:en
Short-container-title:Journal of Social Work in End-of-Life & Palliative Care

Author:

Vasquez-Trespalacios Elsa Maria¹,Rivera Rivera Jessica N.²,McIntyre McKenzie²,Santiago-Datil Waleska²,Wenham Robert M.³,Vadaparampil Susan T.²,Buras Andrea L.⁴,Conley Claire C.⁵

Affiliation:

1. School of Medicine, CES University, Medellín, Colombia

2. Department of Health Outcomes & Behavior, Moffitt Cancer Center, Tampa, FL, USA

3. Department of Gynecologic Oncology, Moffitt Cancer Center, Tampa, FL, USA

4. Department of Gynecologic Oncology, Lacks Cancer Center, Grand Rapids, MI, USA

5. Department of Oncology, Georgetown University, Washington, DC, USA

Funder

Pfizer

Tesaro/GSK

Clovis

Genentech

Mersana, Marker Therapeutics

Ovation Diagnostics

AstraZeneca

Novacure

Shattuck Labs

SeaGen

Regeneron

Legend Biotech

Sonnet Biotherapeutics

Eisai

Immunogen

Link Therapeutics

Merck

Anixa Bioscience

On Target Labs

Moffitt Cancer Center Junior Scientist Partnership Fund

National Cancer Institute

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/15524256.2024.2342285

Reference40 articles.

1. Socioeconomic disparities, financial toxicity, and opportunities for enhanced system efficiencies for patients with cancer

2. Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer patients in the United States

3. Financial Hardships Experienced by Cancer Survivors: A Systematic Review

4. American Cancer Society. (2022). Key statistics for ovarian cancer. Retrieved from https://www.cancer.org/cancer/ovarian-cancer/about/key-statistics.html#:∼:text=Ovarian%20cancer%20ranks%20fifth%20in is%20about%201%20in%20108.

5. Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment